Yet after studying pregnant women on SSRIs, from 1996 through 2007, researchers from the Karolinska Institute in Stockholm, Sweden found no increased risks of stillbirth, neonatal death, and
postneonatal death as a direct result of taking this form of anti-depressant.
We used logistic regression to calculate the odds ratio (OR) of ever having breastfed to never having breastfed
for postneonatal death.
We use 1988 US National Maternal and Infant Health Survey (NMIHS) data to analyze the association between breastfeeding and
postneonatal death using a case - control approach.
If more US mothers can be persuaded to breastfeed and indeed it is breastfeeding that accounts for the benefits, then the United States might improve its poor ranking among industrialized countries
for postneonatal death.
The following chart is adapted from Infant, neonatal, and
postneonatal deaths, percent of total deaths, and mortality rates for the 15 leading causes of infant death by race and sex: United States, 2007:
The following chart, adapted from Infant, neonatal, and
postneonatal deaths, percent of total deaths, and mortality rates for the 15 leading causes of infant death by race and sex: United States, 2007 makes that clear.
We first considered
all postneonatal deaths as cases and the live births as controls.
Welcome news for women suffering from depression — according to an article in Science Daily, a study of nearly 30,000 women from Nordic countries found no significant risk of increased stillbirth, neonatal death, or
postneonatal death for those who took a form of anti-depressants, known as selective serotonin reuptake inhibitors (SSRI), while pregnant.